探索模型C-子酸复合物的抗瘤作用背后的机制
Pedro M G Silva1, Pedro F Pinheiro2,3, Sérgio P Camões1
1Research Institute for Medicines (imed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, 1649-003 Lisboa, Portugal.
Molecules (Basel, Switzerland)
|July 29, 2023
概括
两种新的C-子酸金属复合物被研究出了抗癌潜力. 复合体显示出显著的细胞毒性和抑制细胞迁移,而铁复合体影响了氨酸代谢.
科学领域:
- 协调化学 协调化学
- 癌症生物学 癌症生物学
- 代谢学 代谢学 代谢学
背景情况:
- 全球癌症发病率上升和多药耐药性需要新的治疗策略.
- 甲酸金属复合物为抗癌药物开发提供了一个有前途的支架.
研究的目的:
- 为了评估两种C-子酸盐复合物的抗癌潜力:[FeCl2(κ3-Tpm]和[Co(κ3-TpmOH) ]2(NO3) 2.2.
- 用代谢学来研究它们的细胞毒性,细胞迁移抑制和潜在的生物效应.
主要方法:
- 铁和C-子酸盐复合物的合成和表征.
- 在体外细胞毒性和细胞迁移测定B16,HCT116和HaCaT细胞系.
- 未定位的代谢学来识别受影响的生物途径.
主要成果:
- [Co(κ3-TpmOH) 2) ((NO3) 2) 对HCT116细胞表现出显著的细胞毒性,并在所有测试细胞系中抑制细胞迁移.
- [FeCl2(κ3-Tpm) ]显示出有限的细胞毒性,但影响了氨酸代谢途径.
- 代谢学发现,复合物破坏了细胞粘附和膜结构通路.
结论:
- C-酸盐复合物表现出强大的抗增殖和抗迁移活性,可能通过改变细胞粘附机制来调解.
- 铁C-甲酸复合物的生物效应与氨酸代谢有关.
- 这些复合体代表了开发新型抗癌剂的潜在线索.
关键词:
在C-scorpionate中使用.反对移民的反移民运动.防止核武器的扩散.抗癌药物是一种抗癌药物.科巴尔特是什么? 科巴尔特是什么?协调化合物 协调化合物铁是铁,铁是铁,铁是铁.代谢生物组的代谢生物组更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
11:14Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
57.7K
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
